423 related articles for article (PubMed ID: 25894244)
21. Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Vercaigne LM; Zacharias J; Bernstein KN
Clin Nephrol; 2012 Oct; 78(4):287-96. PubMed ID: 22541682
[TBL] [Abstract][Full Text] [Related]
22. A Novel Inside-out Access Approach for Hemodialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion.
Reindl-Schwaighofer R; Matoussevitch V; Winnicki W; Kalmykov E; Gilbert J; Matzek W; Sengölge G
Am J Kidney Dis; 2020 Apr; 75(4):480-487. PubMed ID: 31787341
[TBL] [Abstract][Full Text] [Related]
23. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.
Cesaro S; Cavaliere M; Pegoraro A; Gamba P; Zadra N; Tridello G
Ann Hematol; 2016 Apr; 95(5):817-25. PubMed ID: 26961934
[TBL] [Abstract][Full Text] [Related]
25. Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients.
Ng R; Li X; Tu T; Semba CP
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):45-9. PubMed ID: 14709686
[TBL] [Abstract][Full Text] [Related]
26. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
Jacobs BR; Haygood M; Hingl J
J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
[TBL] [Abstract][Full Text] [Related]
27. Short and long alteplase dwells in dysfunctional hemodialysis catheters.
Macrae JM; Loh G; Djurdjev O; Shalansky S; Werb R; Levin A; Kiaii M
Hemodial Int; 2005 Apr; 9(2):189-95. PubMed ID: 16191068
[TBL] [Abstract][Full Text] [Related]
28. Tip Design of Hemodialysis Catheters Influences Thrombotic Events and Replacement Rate.
Petridis C; Nitschke M; Lehne W; Smith E; Goltz JP; Lehnert H; Meier M
Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):262-267. PubMed ID: 27876561
[TBL] [Abstract][Full Text] [Related]
29. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
[TBL] [Abstract][Full Text] [Related]
30. Alteplase infusion versus dwell for clearance of partially occluded central venous catheters in critically ill pediatric patients.
Ragsdale CE; Oliver MR; Thompson AJ; Evans MC
Pediatr Crit Care Med; 2014 Jul; 15(6):e253-60. PubMed ID: 24751787
[TBL] [Abstract][Full Text] [Related]
31. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis.
Napalkov P; Felici DM; Chu LK; Jacobs JR; Begelman SM
BMC Cardiovasc Disord; 2013 Oct; 13():86. PubMed ID: 24131509
[TBL] [Abstract][Full Text] [Related]
32. The use of tissue plasminogen activator infusion to re-establish function of tunneled hemodialysis catheters.
Dowling K; Sansivero G; Stainken B; Siskin G; Dolen E; Ahn J; Mitchell N
Nephrol Nurs J; 2004; 31(2):199-200. PubMed ID: 15114800
[TBL] [Abstract][Full Text] [Related]
33. Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.
Ponikvar R; Buturović-Ponikvar J
Ther Apher Dial; 2005 Jun; 9(3):250-3. PubMed ID: 15967000
[TBL] [Abstract][Full Text] [Related]
34. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.
Semba CP; Deitcher SR; Li X; Resnansky L; Tu T; McCluskey ER;
J Vasc Interv Radiol; 2002 Dec; 13(12):1199-205. PubMed ID: 12471182
[TBL] [Abstract][Full Text] [Related]
35. Alteplase for hemodialysis access graft thrombolysis.
Sofocleous CT; Hinrichs CR; Weiss SH; Contractor D; Barone A; Bahramipour P; Brountzos E; Kelekis D
J Vasc Interv Radiol; 2002 Aug; 13(8):775-84. PubMed ID: 12171980
[TBL] [Abstract][Full Text] [Related]
36. Interventions for restoring patency of occluded central venous catheter lumens.
van Miert C; Hill R; Jones L
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007119. PubMed ID: 22513946
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
[TBL] [Abstract][Full Text] [Related]
38.
Al-Balas A; Almehmi A; Varma R; Al-Balas H; Allon M
Kidney360; 2022 Jan; 3(1):99-102. PubMed ID: 35368564
[TBL] [Abstract][Full Text] [Related]
39. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer.
Liu CY; Jain V; Shields AF; Heilbrun LK
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):39-44. PubMed ID: 14709685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
